Jeff Reich

CRM typically manages accounts in accordance with its overall investment style focused on a relative value-oriented investment philosophy which is designed to outperform the broad market and pertinent indices over a full market cycle by participating in good market periods and limiting declines in poor periods. They view investment prospects on a long-term basis. The firm systematically and consistently incorporate ESG factors into their research process and portfolio construction as they believe ESG integration complements their fundamental, bottom-up investment style and provide a more complete picture of a company.

Develops therapies for the brain and central nervous system

Develops novel prescription pharmaceutical, over-the-counter and nutritional products

Merlin BioMed invests globally in public and private healthcare companies. The firm's hedge funds and long-term appreciation fund seek maximum capital appreciation from broad-based, global investment in small-, mid- and large-cap public and private companies in the areas of biotechnology, pharmaceuticals, medical devices, healthcare services and research products/services. This investment objective is characterized by an intensive, research-oriented, fundamental, bottom-up approach with a focus on new product innovation as a driver of sales and earnings growth. For private equity, the MerlinNexus objective is to realize long-term capital appreciation from investments in late-stage private companies, PIPEs (private investments in public entities) and select open market transactions. The fund is invested in all segments of the healthcare industry, with an emphasis on product-driven life sciences companies developing breakthrough products that meet clinical needs and can positively alter disease course and associated costs.

Owns and operates hospitals and that provides medical care & telemedicine services

Functions as a College/University

Functions as a College/University